Experience spanning three decades in healthcare, with a wide range of formulations to meet the needs of ailing humanity, Intas Pharmaceuticals headquartered at Ahmedabad (India), is now a force to reckon with, in the global pharma horizon.
Join Us for Regular Vacancy Updates on –
Join Our Facebook Group
With expertise in a range of formulations, from tablets to injectables to newer drug delivery systems, Intas is currently ranked 17th among the Indian Pharma majors. A variety of initiatives in Research and Development, patents and ANDA filing, NDDS, quality manufacturing support, along with approvals by regulatory authorities of many countries has made Intas a global healthcare provider. Pioneering efforts in providing medications for both chronic and acute medical conditions have truly led Intas to live up to its corporate line Expressions for a Healthy Life.
Job Description: Associate Scientist – Formulation & Development
Location: Ahmedabad, Gujarat
Roles and Responsibilities
- Responsible for Lyophilizer Handling and troubleshooting
- Optimization of Lyophilization cycle
- Scouting different formulation excipients for stability studies
- Responsible for formulation & analytical related activities
- Technology transfer and execution of validation batches of drug product of plasma proteins
- Responsible for planning & Execution of small scale and stability batches for all the products
- Method development for excipient analysis and its qualification
- Responsible for stability sample analysis by different techniques ( HPLC, Protein content, ELISA, SDS-PAGE)
- Responsible for designing, planning of strategies of new formulation or dosage forms of existing and new products
Desired Candidate Profile
- The candidate should be well versed with lyophilizer and have work experience in the biotech/biopharma industry only.
Qualification:Â MS/M.Sc(Science), M.Pharma
Experience: 3-7 Years
Salary: Negotiable
Contact Details:
careers@intaspharma.com, job@intaspharma.com, hr_matoda@intaspharma.com
Join Us for Regular Vacancy Updates on –
